SAN DIEGO—Significant numbers of men with enterococcal UTIs are being overtreated and undertreated, according to findings reported here at the Infectious Diseases Society of America annual meeting.

SAN DIEGO—According to researchers, urine cultures yielding vancomycin-resistant, ampicillin-sensitive Enterococcus faecalis (VRASEF) may not always represent a true UTI, and the proper treatment is not well characterized.

SAN DIEGO—The empiric use of trimethoprim-sulfamethoxazole (SXT) to treat uncomplicated UTIs may be contributing to increased SXT resistance and multidrug resistance in the United States.

Five-day courses of nitrofurantoin are equivalent clinically and microbiologically to a three-day course of trimethoprim-sulfamethoxazole for treating acute uncomplicated cystitis in women, researchers say.

CHICAGO—An international survey of uropathogens isolated from women with uncomplicated UTIs suggests that physicians may need to rethink the antibiotics they use for empiric treatment.

The FDA has approved the use of a five-day, once-daily regimen of Levaquin (levofloxacin) 750 mg IV and oral for the treatment of complicated UTI and acute pyelonephritis (AP).

CHICAGO—Diabetes increases the likelihood of UTI recurrences in pre- and post-menopausal women, despite longer treatments with more potent initial antibiotics, a Dutch study shows.

Proteus bacteriuria may be a marker for poor urinary health in spinal-cord injury (SCI) patients.

TORONTO—Guidelines are needed for managing positive urine cultures in the ICU because clinicians often prescribe antibiotics inappropriately, researchers reported here at the annual meeting of the Infectious Diseases Society of America.

TORONTO—Pyuria may not be an accurate indicator of UTI in patients presenting with acute urolithiasis, California researchers report.